The company, which intends to operate as normal throughout the bankruptcy process, entered an agreement to sell its assets to Bausch Health Companies for approximately $200 million. The proposed sale will occur through bidding procedures approved by the bankruptcy court, and Synergy will evaluate competing bids to ensure it receives the highest offer for its assets.
Synergy aims to complete the sale by the end of the first quarter of 2019.
More articles on pharmacy:
Walmart, 3 pharma companies sued over impure drugs
Justice Department wants to drop Supreme Court whistle-blower case against Gilead
GAO finds flaws in FDA’s orphan drug program: 6 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
